Literature DB >> 10082524

Ku-dependent nonhomologous DNA end joining in Xenopus egg extracts.

P Labhart1.   

Abstract

An extract from activated Xenopus eggs joins both matching and nonmatching ends of exogenous linear DNA substrates with high efficiency and fidelity (P. Pfeiffer and W. Vielmetter, Nucleic Acids Res. 16:907-924, 1988). In mammalian cells, such nonhomologous end joining (NHEJ) is known to require the Ku heterodimer, a component of DNA-dependent protein kinase. Here I investigated whether Ku is also required for the in vitro reaction in the egg extract. Immunological assays indicate that Ku is very abundant in the extract. I found that all NHEJ was inhibited by autoantibodies against Ku and that NHEJ between certain combinations of DNA ends was also decreased after immunodepletion of Ku from the extract. The formation of a joint between a DNA end with a 5'-protruding single strand (PSS) and an end with a 3'-PSS, between two ends with 3'-PSS, and between two blunt ends was most Ku dependent. On the other hand, NHEJ between two DNA ends bearing 5'-PSS was Ku independent. These results show that the Xenopus cell-free system will be useful to biochemically dissect the role of Ku in eukaryotic NHEJ.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082524      PMCID: PMC84051          DOI: 10.1128/MCB.19.4.2585

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Joining of nonhomologous DNA double strand breaks in vitro.

Authors:  P Pfeiffer; W Vielmetter
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

2.  Mechanism of interaction between Ku protein and DNA.

Authors:  T Mimori; J A Hardin
Journal:  J Biol Chem       Date:  1986-08-05       Impact factor: 5.157

3.  A novel pathway of DNA end-to-end joining.

Authors:  S Thode; A Schäfer; P Pfeiffer; W Vielmetter
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

4.  The use of Xenopus oocytes for the expression of cloned genes.

Authors:  J B Gurdon; M P Wickens
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  A DNA-activated protein kinase from HeLa cell nuclei.

Authors:  T Carter; I Vancurová; I Sun; W Lou; S DeLeon
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

6.  Purification and characterization of proximal sequence element-binding protein 1, a transcription activating protein related to Ku and TREF that binds the proximal sequence element of the human U1 promoter.

Authors:  M W Knuth; S I Gunderson; N E Thompson; L A Strasheim; R R Burgess
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

7.  Epitopes of the p70 and p80 (Ku) lupus autoantigens.

Authors:  W H Reeves; A Pierani; C H Chou; T Ng; C Nicastri; R G Roeder; Z M Sthoeger
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

8.  The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination.

Authors:  M R Lieber; J E Hesse; S Lewis; G C Bosma; N Rosenberg; K Mizuuchi; M J Bosma; M Gellert
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

9.  Activation of a system for the joining of nonhomologous DNA ends during Xenopus egg maturation.

Authors:  W Goedecke; W Vielmetter; P Pfeiffer
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

10.  Implication of DNA-dependent protein kinase in an early, essential, local phosphorylation event during end-joining of DNA double-strand breaks in vitro.

Authors:  X Y Gu; M A Weinfeld; L F Povirk
Journal:  Biochemistry       Date:  1998-07-07       Impact factor: 3.162

View more
  34 in total

1.  DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining.

Authors:  E Feldmann; V Schmiemann; W Goedecke; S Reichenberger; P Pfeiffer
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

2.  Reconstitution of the mammalian DNA double-strand break end-joining reaction reveals a requirement for an Mre11/Rad50/NBS1-containing fraction.

Authors:  Juren Huang; William S Dynan
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

3.  The influence of DNA double-strand break structure on end-joining in human cells.

Authors:  J Smith; C Baldeyron; I De Oliveira; M Sala-Trepat; D Papadopoulo
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

4.  Biochemical evidence for Ku-independent backup pathways of NHEJ.

Authors:  Huichen Wang; Ange Ronel Perrault; Yoshihiko Takeda; Wei Qin; Hongyan Wang; George Iliakis
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

5.  Probing the nanoscale viscoelasticity of intracellular fluids in living cells.

Authors:  Gernot Guigas; Claudia Kalla; Matthias Weiss
Journal:  Biophys J       Date:  2007-04-06       Impact factor: 4.033

6.  Saccharomyces cerevisiae Sae2- and Tel1-dependent single-strand DNA formation at DNA break promotes microhomology-mediated end joining.

Authors:  Kihoon Lee; Sang Eun Lee
Journal:  Genetics       Date:  2007-06-11       Impact factor: 4.562

7.  The role of DNA polymerase activity in human non-homologous end joining.

Authors:  H Pospiech; A K Rytkönen; J E Syväoja
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

Review 8.  The capacity of oocytes for DNA repair.

Authors:  Jessica M Stringer; Amy Winship; Seng H Liew; Karla Hutt
Journal:  Cell Mol Life Sci       Date:  2018-05-10       Impact factor: 9.261

9.  A Rad50-dependent pathway of DNA repair is deficient in Fanconi anemia fibroblasts.

Authors:  Sarah L Donahue; Colin Campbell
Journal:  Nucleic Acids Res       Date:  2004-06-15       Impact factor: 16.971

10.  Origin-dependent initiation of DNA replication within telomeric sequences.

Authors:  Isabel Kurth; Jean Gautier
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.